Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Ronsheim Matthew Create: Alert

All | News | Filings
Date FiledTypeDescription
07/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2022 4 Ronsheim Matthew (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Disposed/sold 40,000 options to buy @ $5.12, valued at $204.8k
Granted 33,333 options to buy @ $2.44, valued at $81.3k
01/19/2022 4 Ronsheim Matthew (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Granted 125,000 shares @ $0
11/03/2021 4 Ronsheim Matthew (Chief, Pharma Sciences & MFG.) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns: Paid exercise price by delivering 3,669 shares @ $2.94, valued at $10.8k
10/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/11/2020 3 Ronsheim Matthew (See Remarks) has filed a Form 3 on Entasis Therapeutics Holdings Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy